References

1.
Collins FS, Green ED, Guttmacher AE, Guyer MS. A vision for the future of genomics research. Nature. 2003;422(6934):835–47. [PubMed: 12695777]
2.
Zerhouni E. Medicine. The NIH Roadmap. Science. 2003;302(5642):63–72. [PubMed: 14526066]
3.
Dracopoli NC. Pharmacogenomic applications in clinical drug development. Cancer Chemother Pharmacol. 2003;52 Suppl 1:S57–60. [PubMed: 12856151]
4.
Hayes DF. Prognostic and predictive factors for breast cancer: translating technology to oncology. J Clin Oncol. 2005;23(8):1596–7. [PubMed: 15755959]
5.
Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M. et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351(27):2817–26. [PubMed: 15591335]
6.
Terry SF. Learning genetics. Health Aff (Millwood) 2003;22(5):166–71. [PubMed: 14515892]